Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.71 +0.02 (+2.24%)
As of: Oct 22, 2026 · 10:53 AM EDT

Milestone Pharmaceuticals (MIST) EBIT Margin (2021 - 2022)

Updated

Milestone Pharmaceuticals (MIST) recorded EBIT Margin of -1002.00% in Q3 2022.

Analysis

Milestone Pharmaceuticals (MIST) EBIT Margin (2021 - 2022) Analysis & Trends

On a TTM basis, Milestone Pharmaceuticals' EBIT Margin came in at -381.98% as of Sep 30, 2022; for FY2021, it came in at -287.15%.

  • The Q3 2022 figure is the highest quarterly EBIT Margin since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 28.21%
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 37.86%
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn -3.52%
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 20.57%
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn -133.21%
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn 28.37%
10 Milestone Pharmaceuticals 98.60 Mn -72.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -1,002.00%
Jun 30, 2022 -10,636.71%
Jun 30, 2021 4.75%
API Access

Milestone Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=MIST&period=max&api_key=YOUR_API_KEY